Clinical Trial Update: Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab combined with radiotherapy in advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Cell Lung Carcinoma
• Lung Adenocarcinoma
• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Carcinoma，Non-Small-Cell Lung, Metastatic Lung Cancer | Phase 2 | Status: COMPLETED